tci Medicare Compliance & Reimbursement - 2003 Issue 40

Pharmaceuticals: DRUG REBATES REMAIN UNDER OIG'S MICROSCOPE

Feds goad states on Medicaid drug rebate accounting.  The Medicaid drug rebate program has become a compliance flashpoint for pharmaceutical manufacturers - and the HHS Office of Inspector General wants to make sure state Medicaid agencies have their act together when it comes to balancing the books on this hot-button issue. Over the course of the year, the watchdog agency has examined drug rebate programs in dozens of states, calling health departments to the mat if their collection procedures aren't up to snuff. In the latest round of audits, the OIG takes the measure of programs in five...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.